Key FDI Trends in the Pharmaceuticals Sector
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Key FDI Trends in the Pharmaceuticals Sector report and make more profitable business decisions.
Key FDI Trends in the Pharmaceuticals Sector report analyzes global greenfield FDI projects within the Pharmaceuticals sector between 2019 and 2022.
Additionally, the report highlights:
- Leading destination and source markets for Pharmaceuticals FDI
- Top subsectors, themes and business operations for Pharmaceuticals FDI along with key global FDI projects
Note: The report will be delivered within 2-3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance.
Scope
Key FDI Trends in the Pharmaceuticals Sector report provides an overview of greenfield foreign direct investment (FDI) activity globally between 2019 and 2022 in the Pharmaceuticals sector. This report takes a close look at the top FDI projects in the Pharmaceuticals and identifies the key trends driving foreign investment.
The scope of the research includes –
- Leading destinations for Pharmaceuticals FDI broken down by country and city level.
- Leading source markets.
- Top subsectors, themes and business operations.
- Key Pharmaceuticals FDI projects.
Key Highlights
The US is the leading destination market for greenfield pharmaceuticals FDI, while it is also the top source market. Between 2019 and 2022, the pharmaceuticals sector was the fifteenth largest FDI sector in terms of the number of greenfield investments. The pharmaceuticals sector accounts for 2% of global greenfield FDI projects. The leading destination country for pharmaceuticals FDI is the US. Germany, UK and France are also popular pharmaceuticals investment hubs. With respect to outbound FDI, the US was the leading pharmaceuticals source market. US-based companies held a 26.3% share of total outbound pharmaceuticals FDI projects. Germany, UK, Switzerland and Japan are also top source markets for pharmaceuticals FDI.
Reasons to Buy
This report will allow you to:
- Make strategic business decisions using in-depth data.
- Understand where companies are establishing Pharmaceuticals operations internationally.
- Identify potential markets for market entry or expansion strategies.
- Comprehend the key source markets from which Pharmaceuticals investments are originating.
- Gain insights into the competitive landscape and investment patterns of different regions.
- Gain insights into changes in the Pharmaceuticals industry over the years based on subsectors, themes and business operations.
Key Players
Table of Contents
Frequently asked questions
Methodology
Related reports
View more Pharmaceuticals reports